Category: Business and Investments
2009 - A Big Year for the BTK
The Amex Biotech Index, the BTK, outpaced its peer, the Nasdaq Biotech Index, by 29% …
Small Biotechs Spending Less
The median and mean operational cash spending for small public US biotechs (less than 250 …
1 in 4 Biotechs Above 100% - Waterfall Chart YTD
Year to date, 27% of biotech stocks have doubled in price. 65% are in positive …
The Rise and Fall of Undervaluation
If “price to cash” is a usable metric for fair value of a risky biotech …
The booming H1N1 vaccine market
The vaccine market is booming – and biotech companies are just one of the beneficiaries. …
Perspectives on today's IPO candidates
Some speculation is coming back into the sector but most movement in public markets is …
Panelists make it personal
Panelists in the “Making it Personal” session discussed the clinical utility, comparative effectiveness implications and …
The race against pandemic flu
Panelists at this morning’s Therapeutic Workshop, “Predicting a Frontrunner in the Race Against Pandemic Flu” …
Positive results for Logical Therapeutics’ LT-NS001 vs. Naproxen clinical study
Logical Therapeutics, Inc. announced positive results of a Phase I/II clinical trial evaluating the gastrointestinal …
Endocyte awarded patent for vitamin receptor binding drug delivery conjugates
Endocyte, Inc. has been awarded a patent from the United States Patent and Trademark Office …